Intelligent Investor

Iress: Interim result 2018

Wealth management and lending contributed to healthy first-half growth for Iress.
By · 24 Aug 2018
By ·
24 Aug 2018 · 2 min read
Upsell Banner

Recommendation

IRESS Limited - IRE
Buy
below 8.00
Hold
up to 14.00
Sell
above 14.00
Buy Hold Sell Meter
HOLD at $13.68
Current price
$7.70 at 16:40 (19 April 2024)

Price at review
$13.68 at (24 August 2018)

Max Portfolio Weighting
4%

Business Risk
Medium

Share Price Risk
Medium
All Prices are in AUD ($)

After years of pedestrian growth, Iress kicked into gear in the first half of 2018 with an 8% surge in revenue and profit.

The high margin ANZ wealth management division was responsible for most of it, with revenue increasing 9% to $67m and operating earnings rising 8% to $49.5m.

The much smaller lending division also performed well with revenue increasing 32% to $8.4m and operating earnings rising 39% to $6.8m, as a number of one-off projects were delivered.

Table 1: IRESS interim result 2018
Six months to Jun
($m)
2018 2017 /(–)
(%)
Revenue 229.7 211.8 8
EBITDA 57.7 50.9 13
NPAT 32.0 29.5 8
EPS (c) 18.9 17.7 7
Interim div* (c) 16 16 –
* 60% franked, ex-date 5 Sept

Elsewhere, the ANZ financial markets divisions, Iress's strongest competitively but also its most mature, washed its face with revenue down 1% and profit down 3% to $40.8m.

Management reiterated segment profit guidance of 3–7% on a constant currency basis for the full year, but the statutory result could be slightly higher if currency levels hold in the second half.

Iress has a lot going for it, with business-critical products that customers find awfully difficult to replace, as well as lots of recurring revenue that converts to high levels of cash flow.

The trouble is that, after today's price surge of 11%, Iress's free cash flow yield has whittled into the low single digits. If you expect long-term growth to be pedestrian, as we do, it becomes increasingly hard to generate an acceptable return that compensates for the risks. Management's track record with acquisitions, which have become the main pillar for growth, is also patchy.

We've left our price guide unchanged, but our trigger finger is getting increasingly itchy as the price approaches our $14 sell price. HOLD.

IMPORTANT: Intelligent Investor is published by InvestSMART Financial Services Pty Limited AFSL 226435 (Licensee). Information is general financial product advice. You should consider your own personal objectives, financial situation and needs before making any investment decision and review the Product Disclosure Statement. InvestSMART Funds Management Limited (RE) is the responsible entity of various managed investment schemes and is a related party of the Licensee. The RE may own, buy or sell the shares suggested in this article simultaneous with, or following the release of this article. Any such transaction could affect the price of the share. All indications of performance returns are historical and cannot be relied upon as an indicator for future performance.
Share this article and show your support

Join the Conversation...

There are comments posted so far.

If you'd like to join this conversation, please login or sign up here